Babesia canis merozoite surface antigen 1 antibody and antigen (recombinant protein)

Diagnostic anti-Babesia canis merozoite surface antigen 1 antibodies pairs and antigen for animal health (animal Dog/Canine, Bovines/Cattle, Equine/Horse infectious disease ) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Neurodegenerative diseases diagnostics products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-VT-P261-Tg001-Ag01 Recombinant Babesia canis merozoite surface antigen 1 protein 3090
GMP-VT-P261-Tg001-Ab01 Anti-Babesia canis merozoite surface antigen 1 mouse monoclonal antibody (mAb) 1953
GMP-VT-P261-Tg001-Ab02 Anti-Babesia canis merozoite surface antigen 1 mouse monoclonal antibody (mAb) 1953
GMP-VT-P261-Tg001-Ab03 Anti-Babesia canis merozoite surface antigen 1 human monoclonal antibody (mAb) 1953
GMP-VT-P261-Tg001-Ab04 Anti-Babesia canis merozoite surface antigen 1 human monoclonal antibody (mAb) 1953

Size: 1mg | 10mg | 100mg



Product Description

Cat No. of Products GMP-VT-P261-Tg001-Ag01
Product Name Recombinant Babesia canis merozoite surface antigen 1 protein
Pathogen not infectious
Target/Biomarker merozoite surface antigen 1
Expression platform E.coli
Isotypes Recombinant Antigen
Bioactivity validation Anti-not infectious merozoite surface antigen 1 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in not infectious level test of animal Dog/Canine, Bovines/Cattle, Equine/Horse with Babesia canis infection.
Tag His
Products description Recombinant Babesia canis merozoite surface antigen 1 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-VT-P261-Tg001-Ab01, GMP-VT-P261-Tg001-Ab02
Product Name Anti-Babesia canis merozoite surface antigen 1 mouse monoclonal antibody (mAb)
Pathogen not infectious
Target/Biomarker merozoite surface antigen 1
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation Recombinant not infectious merozoite surface antigen 1 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-not infectious antibodies in not infectious level test of animal Dog/Canine, Bovines/Cattle, Equine/Horse with Babesia canis infection.
Tag mFc
Products description Anti-Babesia canis merozoite surface antigen 1 mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-VT-P261-Tg001-Ab03, GMP-VT-P261-Tg001-Ab04
Product Name Anti-Babesia canis merozoite surface antigen 1 human monoclonal antibody (mAb)
Pathogen not infectious
Target/Biomarker merozoite surface antigen 1
Expression platform CHO
Isotypes Human IgG1
Bioactivity validation Recombinant not infectious merozoite surface antigen 1 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-not infectious antibodies in not infectious level test of animal Dog/Canine, Bovines/Cattle, Equine/Horse with Babesia canis infection.
Tag hFc
Products description Anti-Babesia canis merozoite surface antigen 1 human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker information

    Babesia is a protozoan parasite found to infect vertebrate animals, mostly livestock mammals and birds, but also occasionally humans. Common names of the disease that Babesia microti causes are Texas cattle fever, redwater fever, tick fever, and Nantucket fever.Canine babesiosis is a hemoprotozoan infection typically caused by Babesia canis or Babesia gibsoni. Babesia gibsoni is a tickborne protozoal blood parasite that causes hemolytic anemia, thrombocytopenia, lethargy, and splenomegaly. quine babesiosis in India has always been a severe and life-threatening disease attributed to infection with Theileria equi and Babesia caballi. These organisms are not host-specific, as both T. equi and B. caballi are reported in dogs. Likewise, Babesia canis canis and Babesia canis rossi, the common causative agents in canines, have also been identified in horses. However, no molecular evidence of Babesia gibsoni has been reported in horses in India. A 5-year-old Thoroughbred gelding residing in Bengaluru showed signs of recurrent intermittent fever, inappetence, poor performance, anaemia and depression. A regular complete blood count and biochemical profile were done, however, the results were unresponsive to treatment interventions. The blood sample was submitted for screening equine haemoprotozoans using polymerase chain reaction. The current blood sample was screened for haemoprotozoans. The sample was positive for B. gibsoni and was confirmed by sequencing. Basic Local Alignment Search Tool (BLAST) search against GenBank revealed the highest similarity (95.17%, Accession No. MN385430.1) with B. gibsoni 18s rRNA partial sequence.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.

    Comments


    No comments yet.

    Leave a comment